Skip to main menu Skip to main content Skip to footer

Currently Enrolling Studies

Clinical Research

Expand each section to learn more.

Diabetic Macular Edema

CAPRI / EYP-1901-304 / Eyepoint, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Neovascular Age-Related Macular Degeneration (nAMD or Wet AMD)

4Front-2 / 4D-150-C004 / 4D Molecular Therapeutics, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Protocol AO / DRCR Retina Network / Jaeb Center for Health Research.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Macular Edema Secondary to Inflammation (MESI)

Peak and Pinnacle / KSMP001 / Kodiak Sciences, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Active Studies – Not Currently Enrolling

Neovascular Age-Related Macular Degeneration (nAMD or Wet AMD)

Ocular SOL-R / OTX-TKI-2023-AMD-303 / Ocular Therapeutix, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Ocular SOL / OTX-TKI-2023-AMD-301 / Ocular Therapeutix, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Daybreak / KS301P109 / Kodiak Sciences, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Artemis / ADVM-022-12 / Adverum Biotechnologies, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

4FRONT-1 / 4D-150-C003 / 4D Molecular Therapeutics, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

Geographic Atrophy (GA)

Archer II / ANX007-GA-02 / Annexon, Inc.

Study Details – ClinicalTrials.gov

Full Eligibility Criteria

⇧